Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Total Non-Current Liabilities: 2020-2024

Historic Total Non-Current Liabilities for Whitehawk Therapeutics (WHWK) over the last 2 years, with Dec 2024 value amounting to $17.6 million.

  • Whitehawk Therapeutics' Total Non-Current Liabilities was N/A to $17.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $17.6 million, marking a year-over-year change of. This contributed to the annual value of $17.6 million for FY2024, which is N/A change from last year.
  • Whitehawk Therapeutics' Total Non-Current Liabilities amounted to $17.6 million in FY2024, which was down 43.39% from $31.2 million recorded in FY2020.
  • Whitehawk Therapeutics' Total Non-Current Liabilities' 5-year high stood at $31.2 million during FY2020, with a 5-year trough of $17.6 million in FY2024.
  • In the last 1 years, Whitehawk Therapeutics' Total Non-Current Liabilities had a median value of $17.6 million in 2024 and averaged $17.6 million.